SLC5A2 and diabetes mellitus: Taken together, the results of studies indicate that SGLT2 inhibitors may improve impaired indices of ventricular repolarization heterogeneity, but whether similar results are observed in patients with heart failure or chronic kidney disease in the absence of diabetes mellitus requires further investigation.